Review Article
Medicinal Effect, In Silico Bioactivity Prediction, and Pharmaceutical Formulation of Ageratum conyzoides L.: A Review
Table 3
Types of ageratum extract formulated in pharmaceutical dosage form, the respective active ingredients, and the protein target being studied.
| Extract | Formulation | Active ingredient | Protein target | Part | Solvent |
| Root | Ethanol | Ointment | Alkaloids | Ornithine delta-aminotransferase |
| Aerial part | Methanol | Emulsifiable | Precocene I | Cyclooxygenase-2, MMP-9 | Concentrate | Precocene II |
| Aerial part | Dichloromethane | Emulsifiable | Precocene I | Cyclooxygenase-2, MMP-9 | Concentrate | Precocene II |
| Aerial part | Hexane | Emulsifiable concentrate | Precocene I | Cyclooxygenase-2, MMP-9 | Precocene II |
| Leaves | Ethanol | Gel | Alkaloids, flavonoids | Ornithine delta-aminotransferase, MMP-9 |
| Aerial part | Ethanol | Nanoemulgel | Alkaloids, flavonoids | Ornithine delta-aminotransferase, MMP-9 |
|
|